Thirty years of experience of drug development. Skill areas development and validation of quality control methods. Author and approver of several external regulatory documents e.g. CTA, NDA, MAA. An expert regarding the regulatory landscape connected to quality control and building adequate control strategy of medicines. In an internal innovation AstraZeneca board to evaluate new techniques to characterize and control product quality. Membership in EDQM working party in Strasbourg and in the research council of the Swedish Pharmaceutical Society. Connected to Uppsala university as associate professor - education five to ten times per year.Member of an internal board to evaluate and approve money to S&T innovation proposals. Broad experience with the area to develope new medicines. Drive a new concept how to use scientific knowledge to build a Control Strategy for new medicines. This to minimize regulatory interactions and build regulatory flexibility.